vs
Apellis Pharmaceuticals, Inc.（APLS）与狮门娱乐（STRZ）财务数据对比。点击上方公司名可切换其他公司
狮门娱乐的季度营收约是Apellis Pharmaceuticals, Inc.的1.6倍（$320.9M vs $199.9M），狮门娱乐净利率更高（-16.4% vs -29.5%，领先13.1%），Apellis Pharmaceuticals, Inc.同比增速更快（-5.9% vs -7.5%），Apellis Pharmaceuticals, Inc.自由现金流更多（$-14.3M vs $-31.3M），过去两年Apellis Pharmaceuticals, Inc.的营收复合增速更高（7.7% vs -40.6%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
Starz娱乐集团（原狮门娱乐）是一家加拿大裔美国合资娱乐企业，1997年由弗兰克·朱斯特拉创立，目前总部坐落于加利福尼亚州圣莫尼卡，注册经营原籍为不列颠哥伦比亚省温哥华，在影视内容制作发行领域拥有深厚行业积淀。
APLS vs STRZ — 直观对比
营收规模更大
STRZ
是对方的1.6倍
$199.9M
营收增速更快
APLS
高出1.6%
-7.5%
净利率更高
STRZ
高出13.1%
-29.5%
自由现金流更多
APLS
多$17.0M
$-31.3M
两年增速更快
APLS
近两年复合增速
-40.6%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $320.9M |
| 净利润 | $-59.0M | $-52.6M |
| 毛利率 | — | — |
| 营业利润率 | -25.6% | -10.8% |
| 净利率 | -29.5% | -16.4% |
| 营收同比 | -5.9% | -7.5% |
| 净利润同比 | -62.2% | -71.9% |
| 每股收益（稀释后） | $-0.40 | $-3.15 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSSTRZ
| Q4 25 | $199.9M | — | ||
| Q3 25 | $458.6M | $320.9M | ||
| Q2 25 | $178.5M | $319.7M | ||
| Q1 25 | $166.8M | — | ||
| Q4 24 | $212.5M | $970.5M | ||
| Q3 24 | $196.8M | $346.9M | ||
| Q2 24 | $199.7M | $347.6M | ||
| Q1 24 | $172.3M | — |
净利润APLSSTRZ
| Q4 25 | $-59.0M | — | ||
| Q3 25 | $215.7M | $-52.6M | ||
| Q2 25 | $-42.2M | $-42.5M | ||
| Q1 25 | $-92.2M | — | ||
| Q4 24 | $-36.4M | $-21.9M | ||
| Q3 24 | $-57.4M | $-30.6M | ||
| Q2 24 | $-37.7M | $4.2M | ||
| Q1 24 | $-66.4M | — |
营业利润率APLSSTRZ
| Q4 25 | -25.6% | — | ||
| Q3 25 | 48.7% | -10.8% | ||
| Q2 25 | -18.6% | -8.4% | ||
| Q1 25 | -50.0% | — | ||
| Q4 24 | -12.3% | 3.7% | ||
| Q3 24 | -24.0% | -4.9% | ||
| Q2 24 | -14.7% | 2.9% | ||
| Q1 24 | -36.0% | — |
净利率APLSSTRZ
| Q4 25 | -29.5% | — | ||
| Q3 25 | 47.0% | -16.4% | ||
| Q2 25 | -23.6% | -13.3% | ||
| Q1 25 | -55.3% | — | ||
| Q4 24 | -17.1% | -2.3% | ||
| Q3 24 | -29.2% | -8.8% | ||
| Q2 24 | -18.9% | 1.2% | ||
| Q1 24 | -38.5% | — |
每股收益（稀释后）APLSSTRZ
| Q4 25 | $-0.40 | — | ||
| Q3 25 | $1.67 | $-3.15 | ||
| Q2 25 | $-0.33 | $-2.54 | ||
| Q1 25 | $-0.74 | — | ||
| Q4 24 | $-0.30 | $-0.09 | ||
| Q3 24 | $-0.46 | $-1.83 | ||
| Q2 24 | $-0.30 | $0.26 | ||
| Q1 24 | $-0.54 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $37.0M |
| 总债务越低越好 | — | $608.7M |
| 股东权益账面价值 | $370.1M | $663.2M |
| 总资产 | $1.1B | $2.0B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资APLSSTRZ
| Q4 25 | $466.2M | — | ||
| Q3 25 | $479.2M | $37.0M | ||
| Q2 25 | $370.0M | $51.6M | ||
| Q1 25 | $358.4M | — | ||
| Q4 24 | $411.3M | $200.5M | ||
| Q3 24 | $396.9M | $229.6M | ||
| Q2 24 | $360.1M | $192.5M | ||
| Q1 24 | $325.9M | — |
总债务APLSSTRZ
| Q4 25 | — | — | ||
| Q3 25 | — | $608.7M | ||
| Q2 25 | — | $611.7M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $2.4B | ||
| Q3 24 | — | $2.1B | ||
| Q2 24 | — | $1.5B | ||
| Q1 24 | $93.1M | — |
股东权益APLSSTRZ
| Q4 25 | $370.1M | — | ||
| Q3 25 | $401.2M | $663.2M | ||
| Q2 25 | $156.3M | $712.3M | ||
| Q1 25 | $164.2M | — | ||
| Q4 24 | $228.5M | $-168.3M | ||
| Q3 24 | $237.1M | $935.9M | ||
| Q2 24 | $264.3M | $973.1M | ||
| Q1 24 | $266.7M | — |
总资产APLSSTRZ
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.1B | $2.0B | ||
| Q2 25 | $821.4M | $2.1B | ||
| Q1 25 | $807.3M | — | ||
| Q4 24 | $885.1M | $7.2B | ||
| Q3 24 | $901.9M | $7.1B | ||
| Q2 24 | $904.5M | $7.2B | ||
| Q1 24 | $831.9M | — |
负债/权益比APLSSTRZ
| Q4 25 | — | — | ||
| Q3 25 | — | 0.92× | ||
| Q2 25 | — | 0.86× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.24× | ||
| Q2 24 | — | 1.59× | ||
| Q1 24 | 0.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $-26.1M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $-31.3M |
| 自由现金流率自由现金流/营收 | -7.1% | -9.8% |
| 资本支出强度资本支出/营收 | 0.1% | 1.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $45.0M | $-317.7M |
8季度趋势，按日历期对齐
经营现金流APLSSTRZ
| Q4 25 | $-14.2M | — | ||
| Q3 25 | $108.5M | $-26.1M | ||
| Q2 25 | $4.4M | $65.4M | ||
| Q1 25 | $-53.4M | — | ||
| Q4 24 | $19.4M | $-335.3M | ||
| Q3 24 | $34.1M | $9.1M | ||
| Q2 24 | $-8.3M | $-33.5M | ||
| Q1 24 | $-133.0M | — |
自由现金流APLSSTRZ
| Q4 25 | $-14.3M | — | ||
| Q3 25 | $108.3M | $-31.3M | ||
| Q2 25 | $4.4M | $58.5M | ||
| Q1 25 | $-53.4M | — | ||
| Q4 24 | $19.3M | $-349.3M | ||
| Q3 24 | — | $4.4M | ||
| Q2 24 | $-8.4M | $-38.4M | ||
| Q1 24 | $-133.3M | — |
自由现金流率APLSSTRZ
| Q4 25 | -7.1% | — | ||
| Q3 25 | 23.6% | -9.8% | ||
| Q2 25 | 2.5% | 18.3% | ||
| Q1 25 | -32.0% | — | ||
| Q4 24 | 9.1% | -36.0% | ||
| Q3 24 | — | 1.3% | ||
| Q2 24 | -4.2% | -11.0% | ||
| Q1 24 | -77.3% | — |
资本支出强度APLSSTRZ
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.0% | 1.6% | ||
| Q2 25 | 0.0% | 2.2% | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.0% | 1.4% | ||
| Q3 24 | 0.0% | 1.4% | ||
| Q2 24 | 0.0% | 1.4% | ||
| Q1 24 | 0.2% | — |
现金转化率APLSSTRZ
| Q4 25 | — | — | ||
| Q3 25 | 0.50× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -7.98× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
STRZ
| Over The Top Subscription Service OTT | $222.8M | 69% |
| Linear Subscription Service | $98.1M | 31% |
